Growth Metrics

Novavax (NVAX) Convertible Debt: 2016-2025

Historic Convertible Debt for Novavax (NVAX) over the last 10 years, with Sep 2025 value amounting to $243.8 million.

  • Novavax's Convertible Debt rose 44.06% to $243.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.8 million, marking a year-over-year increase of 44.06%. This contributed to the annual value of $169.7 million for FY2024, which is 0.99% up from last year.
  • Novavax's Convertible Debt amounted to $243.8 million in Q3 2025, which was up 42.95% from $170.6 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Convertible Debt peaked at $324.5 million during Q3 2022, and registered a low of $166.5 million during Q4 2022.
  • For the 3-year period, Novavax's Convertible Debt averaged around $175.5 million, with its median value being $168.8 million (2024).
  • Its Convertible Debt has fluctuated over the past 5 years, first slumped by 48.54% in 2022, then spiked by 44.06% in 2025.
  • Novavax's Convertible Debt (Quarterly) stood at $323.5 million in 2021, then slumped by 48.54% to $166.5 million in 2022, then grew by 0.93% to $168.0 million in 2023, then climbed by 0.99% to $169.7 million in 2024, then spiked by 44.06% to $243.8 million in 2025.
  • Its Convertible Debt was $243.8 million in Q3 2025, compared to $170.6 million in Q2 2025 and $170.1 million in Q1 2025.